Skip to main content
Clinical Trials/NCT04206449
NCT04206449CompletedNot Applicable

Sleep Thermography for Diagnosis of Obstructive Sleep Apnea (OSA)

Hospital Universitario Araba1 site in 1 country198 target enrollmentStarted: September 10, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
198
Locations
1
Primary Endpoint
Apnea-Hypopnea Index (AHI)

Study Overview

Brief Summary

To assess the diagnostic validity and cost-effectiveness of an infrared thermography system in adults with clinical suspicion of Obstructive Sleep Apnea (OSA).

Detailed Description

AIMS: To assess the diagnostic validity and cost-effectiveness of an infrared thermography system, integrated in an expert diagnostic algorithm (TIS), to determine the sleep stages and identify respiratory events, compared to conventional polysomnography (PSG) in adults with clinical suspicion of Obstructive Sleep Apnea (OSA).

METODOLOGY: DESIGN: Prospective, unicentric, randomized and blinded study carried out into two phases: Phase I: Development of the tool in 99 full valuable adults with suspected OSA (PSG recruitment, coordination and quality control, image capture, Information and development of the expert system); Phase II: Validation of the tool compared with the PSG in another group of 99 full valuable adults with suspected OSA. INSTRUMENTALIZATION: a) Clinical history and anthropometric variables; b) Sleep and quality of life questionnaires; c) PSG; d) TIS; e) Cost-effectiveness study.

ANALYSYS : The validity of the results of the TIS will be analyzed compared with the results of the PSG. The agreement measure will be established according to the different categories of the Apnea-Hypopnea Index (AHI), using ROC (Receiver Operating Characteristic) curves and the area under the curve. The investigators will also validate the therapeutic decisions made with PSG compared to those performed with the TIS. Finally, a cost-effectiveness study will be performed.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Men and women over 18 years to 75 years old, with clinical suspicion of OSA
  • •Written informed consent signed

Exclusion Criteria

  • •Place of residence more than 100 km from the hospital
  • •Severe, unstable or exacerbated cardio-vascular, cerebro-vascular or respiratory disease, that makes it impossible to carry out adequate studies
  • •Presence of insomnia, depressive syndrome or epilepsia
  • •Patients diagnosed of any acute inflammatory episode of the cranium-maxillo-facial area or any systemic infection that develops with fever> 38 ºC at the time of testing
  • •Patient with malformation syndromes, Down syndrome and neuromuscular diseases
  • •Patient on active treatment with Positive continuous pressure (CPAP )

Arms & Interventions

Infrared thermography system

Experimental

Therapeutic decision taken with infrared thermography system, integrated in an expert diagnostic algorithm (TIS), to determine the sleep stages and Apnea-Hypopnea Index (AHI).

Intervention: Therapeutic decision Infrared thermgraphy system (Other)

Standard Polysomnography (PSG)

Active Comparator

Therapeutic decision taken with Standard Polysomnography (PSG), to determine the sleep stages and Apnea-Hypopnea Index (AHI)

Intervention: Therapeutic decision PSG (Other)

Outcomes

Primary Outcomes

Apnea-Hypopnea Index (AHI)

Time Frame: Baseline

Count the respiratory events (apneas and hypopneas) that occur during sleep using a high sensitivity infrared thermal camera integrated in an expert diagnostic algorithm (TIS).

Secondary Outcomes

  • Anthropometric variables (Body mass index)(baseline and at 6 month)
  • Validation of the therapeutic decision(6 month)
  • Blood pressure(baseline and at 6 month)
  • Quality of life (EuroQOL test)(baseline and at 6 month)
  • Epworth Sleepiness Scale(baseline and at 6 month)
  • Cost effectiveness analysis(6 month)
  • STOP-Bang Questionnaire(baseline and at 6 month)
  • Berlin questionnaire(baseline and at 6 month)

Investigators

Sponsor
Hospital Universitario Araba
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Carlos Javier Egea Santaolalla,Ph

Principal Investigator, MD, PhD

Hospital Universitario Araba

Study Sites (1)

Loading locations...

Similar Trials